Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
16%
Apheresis
8%
Bortezomib
100%
CD34+ Cells
8%
Dose Level
8%
Dose-limiting Toxicity
8%
Engraftment
8%
Graft Viability
8%
Granulocyte Colony-stimulating Factor (G-CSF)
100%
Institutional Guidelines
8%
Microliter
16%
Mobilization Effect
25%
Multiple Myeloma
100%
Myeloma Cells
16%
Peripheral Blood
16%
Phase I Study
100%
Purging
8%
Randomized Trial
8%
Stem Cell Mobilization
100%
Medicine and Dentistry
Apheresis
8%
Autologous Stem Cell Transplantation
16%
Bortezomib
100%
Engraftment
8%
Granulocyte Colony Stimulating Factor
100%
Multiple Myeloma
100%
Myeloma Cell
16%
Single Drug Dose
8%
Stem Cell Mobilization
100%
Immunology and Microbiology
Apheresis
11%
Autologous Stem Cell Transplantation
22%
CD34
11%
Engraftment
11%
Granulocyte Colony-Stimulating Factor
100%
Multiple Myeloma
100%
Myeloma Cell
22%
Stem Cell
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bortezomib
100%
Granulocyte Colony Stimulating Factor
100%
Multiple Myeloma
100%
Myeloma
8%
Material Science
Colony Stimulating Factor
100%
Stem Cell
100%